Drug Archives - Cannabis Business Executive - Cannabis and Marijuana industry news

Are the New FDA Warning Letters Signaling Treatment of Hemp Extracts as Over the Counter Monographs?

The FDA issued two new warning letters on March 22, 2021. Previous rounds of warning letters have focused on whether the companies have made statements that would make the product a drug. These have focused on such things as (1)…

The “Right to Try” Psilocybin and New Drug Therapies

by Vince Sliwoski, Attorney at Harris Bricken I was talking to another lawyer about last week’s vote by Oregonians to legalize psilocybin therapy here in the state. We discussed how licensed facilities won’t be up and running for a few…

CBD DD: Key Considerations When Conducting Due Diligence on Cannabis Companies

While the regulatory atmosphere surrounding cannabis and cannabis-related products is still in flux, private equity and other investors have begun to consider the potential for transactions in the industry. This article explores the key due diligence and regulatory compliance considerations…

New Law Removes Major Barrier for Hemp-based CBD Industry

By Rebecca Gwilt On December 12, 2018, Congress passed the 2018 Farm Bill (The “Agriculture Improvement Act of 2018” or the “Bill”), which includes provisions that exempt Cannabis plants with lower than 0.3% THC content (also called “Hemp”) from the…